Summit Therapeutics Total Long Term Liabilities 2015-2024 | SMMT

Summit Therapeutics total long term liabilities for the quarter ending December 31, 2024 were $0.005B, a 95.15% decline year-over-year.

  • Summit Therapeutics total long term liabilities for 2024 were $0.005B, a 95.15% decline from 2023.
  • Summit Therapeutics total long term liabilities for 2023 were $0.105B, a 78.98% decline from 2022.
  • Summit Therapeutics total long term liabilities for 2022 were $0.499B, a 11064.81% increase from 2021.

Summit Therapeutics Total Long Term Liabilities 2015-2024 | SMMT

  • Summit Therapeutics total long term liabilities for 2024 were $0.005B, a 95.15% decline from 2023.
  • Summit Therapeutics total long term liabilities for 2023 were $0.105B, a 78.98% decline from 2022.
  • Summit Therapeutics total long term liabilities for 2022 were $0.499B, a 11064.81% increase from 2021.